Attending the 6th CNS Drug Delivery Summit in Boston
The 6th CNS Drug Delivery Summit in Boston on Dec 4-5, 2024 was an invaluable opportunity to connect with [...]
NEUROSTECH recognized among the TOP 101 companies at the Spain Up Nation awards
NEUROSTECH has been selected as one of the 101 winning companies at the prestigious TOP101 Spain Up Nation Awards. [...]
NEUROSTECH in the Spain‑Singapore Expert Dialogue on Neuroscience
NEUROSTECH participated in the Expert Dialogue on Neuroscience, Technology and Artificial Intelligence, organized by CDTI in Singapore on October [...]
Attending the 2nd Science and Innovation Fair in Asturias
NEUROSTECH took part in the 2nd Science and Innovation Fair of Asturias, showcasing its advanced solutions for treating neurological [...]
NEUROSTECH founders featured in VENUS FOUNDERS Podcast
The co-founders of NEUROSTECH, Gabriel Álvarez Menéndez (CEO) and Catuxa Prado (CSO), were recently featured in the latest episode [...]
Selected among the Top 100 Spanish Startups of 2023
NEUROSTECH has been recognized as one of the top 100 startups of 2023 by the Association of Science and [...]
New project in collaboration with public-private partners
NEUROSTECH has commenced a new project aimed at developing one of its cutting-edge technologies for controlled release therapies targeting [...]
Showcasing innovation at Asturias Investor’s Day
NEUROSTECH had the opportunity to present its business plans during the Asturias Investor's Day, organized by CEEI Asturias, the [...]
NEUROSTECH press highlight
La Voz de Asturias has published a report highlighting NEUROSTECH’s activities, particularly the research and development of new medical devices [...]
NEUROSTECH selected by SAFE‑N‑Medtech
SAFE-N-Medtech (safety testing in the life cycle of nanotechnology-enabled medical technologies for health) is an innovative, EU-funded, open-access platform to [...]